SMTL ID : 8t1p.1

Heterodimeric ABC transporter BmrCD in the occluded conformation bound to ADPVi: BmrCD_OC-ADPVi

Coordinates

PDB Format Compare

Method

ELECTRON MICROSCOPY

Oligo State

hetero-1-1-mer

Ligands

1 x ATP: ADENOSINE-5'-TRIPHOSPHATE(Non-covalent)

ATP.1: 27 residues within 4Å: Chain A: E.132, Y.368, S.370, S.371, N.375, K.394, T.395, G.396, S.397, G.398, K.399, T.400, T.401, K.404, Y.410, Q.441, H.553 Chain B: L.549, S.565, T.566, L.567, S.568, S.569, G.570, E.571, H.596 Ligands: MG.2 21 PLIP interactions: 8 interactions with chain B, 13 interactions with chain A Hydrogen bonds: B:S.565, B:T.566, B:S.568, B:S.568, B:G.570, B:E.571, B:E.571, B:H.596, A:G.396, A:S.397, A:G.398, A:K.399, A:T.400, A:T.401, A:Q.441, A:Q.441 Salt bridges: A:K.399, A:K.399, A:H.553 pi-Stacking: A:Y.368, A:Y.368

2 x MG: MAGNESIUM ION(Non-covalent)

MG.2: 5 residues within 4Å: Chain A: T.400, Q.441, D.521 Chain B: S.569 Ligands: ATP.1 1 PLIP interactions: 1 interactions with chain A Metal complexes: A:T.400 MG.14: 5 residues within 4Å: Chain A: S.498, G.499 Chain B: S.470, Q.511 Ligands: AOV.13 1 PLIP interactions: 1 interactions with chain B Metal complexes: B:S.470

21 x POV: (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate(Non-covalent)

POV.3: 8 residues within 4Å: Chain A: L.27, K.28, G.31, F.34, I.45, I.158, V.162, M.166 Ligand excluded by PLIP POV.4: 13 residues within 4Å: Chain A: S.164, T.165, M.168, L.191, P.192, M.194, A.195, I.196, I.198, S.199, S.203, M.314, I.317 Ligand excluded by PLIP POV.5: 6 residues within 4Å: Chain A: E.77, L.80, F.81, I.83, G.84, F.87 Ligand excluded by PLIP POV.6: 7 residues within 4Å: Chain A: W.181, K.182, F.185, A.186, I.189, Y.285 Ligands: POV.9 Ligand excluded by PLIP POV.7: 5 residues within 4Å: Chain A: S.25, L.200, S.203, K.204 Ligands: POV.8 Ligand excluded by PLIP POV.8: 12 residues within 4Å: Chain A: A.197, L.200, Y.201, K.204, R.208, K.259, F.262, I.263, L.266, F.267, T.270 Ligands: POV.7 Ligand excluded by PLIP POV.9: 12 residues within 4Å: Chain A: A.186, I.189, P.190, L.280, I.281, G.284, Y.285, F.288, R.292 Chain B: I.153 Ligands: POV.6, POV.25 Ligand excluded by PLIP POV.10: 8 residues within 4Å: Chain A: I.95, Y.98, F.99, H.102, Q.103 Chain B: N.331 Ligands: POV.11, POV.21 Ligand excluded by PLIP POV.11: 11 residues within 4Å: Chain A: Y.37, L.39, R.40, I.43, L.47, A.92, I.95, M.96, F.99, Q.103 Ligands: POV.10 Ligand excluded by PLIP POV.12: 14 residues within 4Å: Chain A: L.49, V.53, M.56, F.57, K.60, L.61, M.166, M.169, T.170, L.173, T.174, F.177, L.178, Y.306 Ligand excluded by PLIP POV.15: 6 residues within 4Å: Chain A: Q.255, M.258, K.259, F.262 Chain B: Y.168, Y.172 Ligand excluded by PLIP POV.16: 14 residues within 4Å: Chain B: K.2, I.3, G.4, F.231, V.260, P.261, I.263, W.264, S.267, R.271, F.393, L.396, R.400 Ligands: POV.18 Ligand excluded by PLIP POV.17: 12 residues within 4Å: Chain B: R.15, K.16, I.19, T.20, L.23, L.24, F.165, F.166, Y.168, G.169, Y.172, L.173 Ligand excluded by PLIP POV.18: 19 residues within 4Å: Chain B: G.4, K.5, L.7, W.8, A.11, L.12, R.15, L.18, I.19, V.22, L.174, S.177, A.178, I.181, Y.224, L.228, S.229, V.232 Ligands: POV.16 Ligand excluded by PLIP POV.19: 7 residues within 4Å: Chain B: Y.276, Y.277, S.321, Y.324, F.325, R.328 Ligands: POV.20 Ligand excluded by PLIP POV.20: 6 residues within 4Å: Chain B: R.272, Y.273, S.275, Y.276, Y.277 Ligands: POV.19 Ligand excluded by PLIP POV.21: 12 residues within 4Å: Chain A: F.87, A.91, Y.94, I.95, Y.98, F.99 Chain B: N.331, L.335, L.340, V.343, L.347 Ligands: POV.10 Ligand excluded by PLIP POV.22: 11 residues within 4Å: Chain A: I.83 Chain B: V.255, C.256, A.258, I.259, I.262, I.344, L.347, A.348, V.350, C.351 Ligand excluded by PLIP POV.23: 12 residues within 4Å: Chain B: G.235, M.238, F.239, F.242, T.243, F.246, L.247, L.248, V.250, L.257, V.260 Ligands: POV.24 Ligand excluded by PLIP POV.24: 21 residues within 4Å: Chain B: T.26, V.29, G.30, L.33, T.34, F.37, I.38, K.40, K.41, D.44, D.45, K.52, I.236, F.239, G.240, T.243, A.244, L.247, S.368, Y.378 Ligands: POV.23 Ligand excluded by PLIP POV.25: 13 residues within 4Å: Chain A: L.280, F.288 Chain B: I.146, K.147, V.150, L.151, I.153, C.154, L.155, G.157, G.158, V.161 Ligands: POV.9 Ligand excluded by PLIP

1 x AOV: ADP ORTHOVANADATE

AOV.13: 25 residues within 4Å: Chain A: M.481, L.482, V.495, A.496, L.497, S.498, G.499, G.500, Q.501, A.526 Chain B: D.202, Y.439, V.445, H.464, T.465, G.466, S.467, G.468, K.469, S.470, S.471, Q.511, E.592, H.623 Ligands: MG.14 20 PLIP interactions: 6 interactions with chain A, 14 interactions with chain B Hydrogen bonds: A:S.498, A:S.498, A:G.499, A:G.500, A:Q.501, A:Q.501, B:D.202, B:H.464, B:S.467, B:G.468, B:K.469, B:K.469, B:S.470, B:S.471, B:Q.511, B:Q.511, B:E.592, B:H.623 Salt bridges: B:K.469 pi-Stacking: B:Y.439

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Tang, Q. et al., Asymmetric conformations and lipid interactions shape the ATP-coupled cycle of a heterodimeric ABC transporter. Nat Commun (2023)

Release Date

2023-11-15

Peptides

Probable multidrug resistance ABC transporter ATP-binding/permease protein YheI: A
Probable multidrug resistance ABC transporter ATP-binding/permease protein YheH: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
C

B
D

Membrane

We predict this structure to be a membrane protein.
Show / Hide

Probable multidrug resistance ABC transporter ATP-binding/permease protein YheI

Probable multidrug resistance ABC transporter ATP-binding/permease protein YheH